LOGIN  |  REGISTER
Amneal Pharmaceuticals
C4 Therapeutics

Universal Health Services Announces Date For First Quarter 2025 Earnings Release And Conference Call

April 09, 2025 | Last Trade: US$223.87 1.27 0.57

KING OF PRUSSIA, Pa., April 9, 2025 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) announced today that it will report results for its first quarter ended March 31, 2025, after the market closes on Monday, April 28, 2025. There will be a conference call for investors and analysts at 9:00 a.m. Eastern time on Tuesday, April 29, 2025.

A live webcast of the call will be available on the company's website at www.uhs.com. To participate via telephone, please register in advance at this link. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call. A re-play of the call will be available for one full year following the live call.

Universal Health Services, Inc. is one of the nation's largest hospital companies, operating through its subsidiaries, acute care hospitals, behavioral health facilities and ambulatory centers located throughout the United States, the United Kingdom, and Puerto Rico. 

Stock Quote

Featured Stock

Chimerix

Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....

CLICK TO LEARN MORE

Featured Stock

Immix Biopharma

Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page